<i>Pediatric Pulmonology</i> 2022 year in review: Rare and diffuse lung disease-Reference-Cited by-全球学者库

Pediatric Pulmonology 2022 year in review: Rare and diffuse lung disease

Published:2023-07-26 Issue:10 Volume:58 Page:2719-2724
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Barber Andrew T.¹,Liptzin Deborah R.²³⁴,Gower William A.⁵^ORCID,Hinds Daniel M.⁶

Affiliation:

1. Department of Pediatrics Virginia Commonwealth University Richmond Virginia USA

2. School of Public and Community Health Sciences University of Montana Missoula Montana USA

3. Department of Pediatrics University of Colorado School of Medicine Aurora Colorado USA

4. Department of Pediatrics University of Washington School of Medicine Seattle Washington USA

5. Division of Pediatric Pulmonology and Program for Rare and Interstitial Lung Disease University of North Carolina School of Medicine Chapel Hill North Carolina USA

6. Department of Pediatrics University of Iowa School of Medicine Iowa City Iowa USA

Abstract

AbstractThe field of rare and diffuse pediatric lung disease continues to evolve and expand rapidly as clinicians and researchers make advancements in the diagnosis and treatment of children's interstitial and diffuse lung disease, non‐cystic fibrosis bronchiectasis, and primary ciliary dyskinesia. Papers published on these topics in Pediatric Pulmonology and other journals in 2022 describe newly recognized disorders, elucidate disease mechanisms and courses, explore potential biomarkers, and assess novel treatments. In this review, we will discuss these important advancements and place them in the context of existing literature.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26603

Reference44 articles.

1. Interstitial lung disease in children with Rubinstein‐Taybi syndrome

2. ABCA3Gene Mutations in Newborns with Fatal Surfactant Deficiency

3. Genotype–Phenotype Correlations for Infants and Children with ABCA3 Deficiency

4. Biologic characterization of ABCA3 variants in lung tissue from infants and children with ABCA3 deficiency

5. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities